Delivery Order SPE2DB25D2207-SPE2DB25FQQFZ
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The award has a ceiling value of $29,018.69 and a completion date of January 15, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,684.53, is for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL), a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The award has a ceiling value of $16,175.68 and a period of performance through December 30, 2024. The contract is a firm-fixed-price delivery order, meaning the price is set and the vendor is responsible for delivering the specified...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used to treat diabetes. The contract has a ceiling value of $10,968.87 and an ultimate completion date of October 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $23,388.81 for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,541.87, is for the provision of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price delivery order contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order worth $27,920.16 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) and has a period of performance through February 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for the treatment of diabetes. The contract is a firm-fixed-price delivery order with a ceiling value of $1,253.32 and a completion date of December 17, 2024. This award is not set aside for any specific business category....
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $24,306.55 and a term ending on August 2, 2024. Amerisourcebergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract with DLA Troop Support Medical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,393.88 and a period of performance through November 1, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...